APEXK Inc., founded in 2011, is a company based in Montreal, Canada.
We are driven by a philosophy of continuous R&D which is articulated around the implementation
of disruptive technologies, solutions and applications, tailored to our target markets, which include
Neurorehabilitation and Athletic Cognitive Enhancement.
Our products strategically serve the purpose of filling the unmet needs of the markets we serve, based on 3 pillars governing our developmental activities, which are science, technology and specific end-user needs.
In 1992, David Tinjust, PhD, a young elite-level soccer player from Europe observed that
performance development models were based solely on physical and technical parameters. Intuitively, he
that the future of sports performance resided in vision and brain capacity enhancement.
With his passion for science he decided to turn his back on a potential career in pro sports, and eventually perfected and patented a revolutionary technology for athletic cognitive enhancement. During this journey, his clinical and research expertise lead him to develop a novel and disruptive neurorehabilitation application.
He has since led the company down a development pathway, that combines telemedicine, virtual reality, artificial intelligence and biosensing. In the last 9 years, David Tinjust has succesfully registered 10 different patents related to our products.
We provide a full techno-ecosystem to support healthcare professionals in the management of the rehabilitation of patients with persistent Post-Concussive symptoms.
We provide a full techno-ecosystem to help athletes maintain and enhance their cognitive-motor
solutions are used by professional hockey players, UFC fighters, professional boxers and professional
The FIFA Medical Center of Excellence in Dubai was first to adopt our cognitive enhancement technology for professional soccer players from around the world.